IMMUNPROTEASOMINHIBITOREN
European patent · EP3571208 · Deleted
Register entry
- Publication number
- EP3571208
- Application number
- EP18716009
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- Deleted
- Specification
- Granted
- Filed
- Jan 16, 2018
- Published
- Nov 27, 2019
- Granted
- Mar 10, 2021
- Deleted
- Aug 25, 2026
- Reason
- Annual fee unpaid
- IPC classes
- C07F 5/02 (2006.01)A61K 31/69 (2006.01)A61P 37/00 (2006.01)
- Priority
- US 201762447717 P 18.01.2017US 201762508771 P 19.05.2017
- PCT application
- PCT/US2018/013823 16.01.2018
- PCT publication
- WO2018/136401 26.07.2018
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Aug 25, 2026
Deleted, fee unpaid
- Status of protective title
- Active → Cancelled
- Cancellation date
- 25.08.2026
- Cause for cancellation
- Non-payment of renewal fee
Published in Swissreg on 25.08.2026
- Feb 1, 2025
Next annual fee due on
- Next annual fee due on
- 31.01.2025 → 31.01.2026
Published in Swissreg on 01.02.2025
- Feb 1, 2024
Change
Published in Swissreg on 01.02.2024
- Feb 1, 2023
Change
Published in Swissreg on 01.02.2023
- Jan 19, 2022
Change
Published in Swissreg on 19.01.2022
- Apr 20, 2021
Agent entered
- Representative
- Ing. Marco Zardi, c/o M. ZARDI & Co. S.A., via Pioda 6, 6900 Lugano
Published in Swissreg on 20.04.2021
- Mar 10, 2021
Granted
Published in Swissreg on 10.03.2021
Parties
Inventor
South San Francisco CA 94080, US
South San Francisco CA 94080, US
South San Francisco CA 94080, US
South San Francisco CA 94080, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.